250 related articles for article (PubMed ID: 29291024)
1. Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis.
Stephenson D; Nahm C; Chua T; Gill A; Mittal A; de Reuver P; Samra J
Oncotarget; 2017 Dec; 8(63):107223-107236. PubMed ID: 29291024
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis.
Cui L; Kwong J; Wang CC
J Ovarian Res; 2015 Jun; 8():38. PubMed ID: 26077676
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis.
Ma X; Xiao Z; Li X; Wang F; Zhang J; Zhou R; Wang J; Liu L
Tumour Biol; 2014 Jun; 35(6):5551-60. PubMed ID: 24563278
[TBL] [Abstract][Full Text] [Related]
4. Circulating and disseminated tumor cells in ovarian cancer: a systematic review.
Romero-Laorden N; Olmos D; Fehm T; Garcia-Donas J; Diaz-Padilla I
Gynecol Oncol; 2014 Jun; 133(3):632-9. PubMed ID: 24657303
[TBL] [Abstract][Full Text] [Related]
5. Association between circulating tumor cells in the peripheral blood and the prognosis of gastric cancer patients: a meta-analysis.
Jin T; Liang PP; Chen ZH; He FJ; Li ZD; Chen ZW; Hu JK; Yang K
Ther Adv Med Oncol; 2023; 15():17588359231183678. PubMed ID: 37435560
[TBL] [Abstract][Full Text] [Related]
6. Correlation of circulating or disseminated tumor cells with the Oncotype DX Recurrence Score.
Singh P; Tevis SE; Hall CS; Meas S; Hwang RF; Lucci A
Breast Cancer Res Treat; 2020 Dec; 184(3):683-687. PubMed ID: 32888140
[TBL] [Abstract][Full Text] [Related]
7. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.
Mathiesen RR; Borgen E; Renolen A; Løkkevik E; Nesland JM; Anker G; Ostenstad B; Lundgren S; Risberg T; Mjaaland I; Kvalheim G; Lønning PE; Naume B
Breast Cancer Res; 2012 Aug; 14(4):R117. PubMed ID: 22889108
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of programmed cell death-ligand 1 expression on circulating tumor cells in various cancers: A systematic review and meta-analysis.
Ouyang Y; Liu W; Zhang N; Yang X; Li J; Long S
Cancer Med; 2021 Oct; 10(20):7021-7039. PubMed ID: 34423578
[TBL] [Abstract][Full Text] [Related]
9. Synchronous Detection of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow Predicts Adverse Outcome in Early Breast Cancer.
Magbanua MJM; Yau C; Wolf DM; Lee JS; Chattopadhyay A; Scott JH; Bowlby-Yoder E; Hwang ES; Alvarado M; Ewing CA; Delson AL; Van't Veer LJ; Esserman L; Park JW
Clin Cancer Res; 2019 Sep; 25(17):5388-5397. PubMed ID: 31142502
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis.
Jiang AM; Zheng HR; Liu N; Zhao R; Ma YY; Bai SH; Tian T; Liang X; Ruan ZP; Fu X; Yao Y
Cancer Control; 2021; 28():10732748211050581. PubMed ID: 34654345
[TBL] [Abstract][Full Text] [Related]
11. Enrichment and detection method for the prognostic value of circulating tumor cells in ovarian cancer: A meta-analysis.
Huang C; Lin X; He J; Liu N
Gynecol Oncol; 2021 May; 161(2):613-620. PubMed ID: 33674144
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for the presence of tumor cells in bone marrow and peripheral blood in breast cancer patients.
Cabinakova M; Mikulova V; Malickova K; Vrana D; Pavlista D; Petruzelka L; Zima T; Tesarova P
Neoplasma; 2015; 62(2):259-68. PubMed ID: 25591591
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of circulating tumor cells and disseminated tumor cells in patients with esophageal cancer: a meta-analysis].
Shi XX; An JH; Huang YE; Zhang YZ; Huang ZY; Zou ZN; Chen Q; Shen H
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 37(2):266-273. PubMed ID: 28219875
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous detection of circulating and disseminated tumor cells in primary breast cancer patients following neoadjuvant chemotherapy.
Walter VP; Taran FA; Wallwiener M; Hahn M; Brucker SY; Hartkopf AD
Arch Gynecol Obstet; 2018 Mar; 297(3):785-790. PubMed ID: 29380106
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer Patients.
Hartkopf AD; Wallwiener M; Hahn M; Fehm TN; Brucker SY; Taran FA
Cancer Res Treat; 2016 Jan; 48(1):115-24. PubMed ID: 25687853
[TBL] [Abstract][Full Text] [Related]
17. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.
Deng G; Krishnakumar S; Powell AA; Zhang H; Mindrinos MN; Telli ML; Davis RW; Jeffrey SS
BMC Cancer; 2014 Jun; 14():456. PubMed ID: 24947048
[TBL] [Abstract][Full Text] [Related]
18. Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy.
Kasimir-Bauer S; Bittner AK; König L; Reiter K; Keller T; Kimmig R; Hoffmann O
Breast Cancer Res; 2016 Feb; 18(1):20. PubMed ID: 26868521
[TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
Gröbe A; Blessmann M; Hanken H; Friedrich RE; Schön G; Wikner J; Effenberger KE; Kluwe L; Heiland M; Pantel K; Riethdorf S
Clin Cancer Res; 2014 Jan; 20(2):425-33. PubMed ID: 24218516
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients.
Molloy TJ; Bosma AJ; Baumbusch LO; Synnestvedt M; Borgen E; Russnes HG; Schlichting E; van't Veer LJ; Naume B
Breast Cancer Res; 2011 Jun; 13(3):R61. PubMed ID: 21672237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
